• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-甲酰氨基-4-羟基-α-(N-1-甲基-2-对甲氧基苯乙氨基甲基)-苄醇半富马酸盐(BD 40A)及其他一些β-肾上腺素能兴奋剂对清醒豚鼠的心肺活动

Cardiorespiratory activitirs of 3-formylamino-4-hydroxy-alpha-(n-1-methyl-2-p-methoxyphenethylaminomethyl)-benzylalcohol-hemifumarate(BD 40A) and some other beta-adrenoceptor stimulants in conscious guinea pigs.

作者信息

Ida H

出版信息

Arzneimittelforschung. 1976;26(7):1337-40.

PMID:12766
Abstract

The beta-stimulant activity of 3-formylamino-4-hydroxy-alpha-(N-1-methoxyphenethylaminomethyl)-benzylalcohol-hemifumarate (BD 40A) was compared with those of isoproterenol, orciprenaline, trimetoquinol and salbutamol in conscious guinea pigs. Bronchodilator effects of BD 40A were most potent among five agonists by s.c., oral and aerosol administration, and were lasting by oral and aerosol administration. BD 40A was similar to isoproterenol, more potent than trimetoquinol, orciprenaline and salbutamol in increasing heart rate by s.c. route. The cardiostimulating effect of BD 40A was more potent than that of isoproterenol, trimetoquinol and salbutamol orally. However, the order of bronchoselectivity (ratio between ED30 beats/min vs. ED50) in conscious guinea pigs was salbutamol greater than BD 40A = trimetoquinol greater than orciprenaline greater than isoproterenol by s.c. administration, and by oral administration the order was BD 40A = salbutamol greater than trimetoquinol = isoproterenol. Orciprenaline showed no beta-stimulating effect in guinea pigs orally. In guinea pigs, BD 40A, like salbutamol, seems to be a beta2-adrenoceptor stimulant.

摘要

在清醒豚鼠中,比较了3-甲酰氨基-4-羟基-α-(N-1-甲氧基苯乙胺甲基)-苄醇半富马酸盐(BD 40A)与异丙肾上腺素、奥西那林、曲美托喹酚和沙丁胺醇的β-激动剂活性。通过皮下、口服和气雾剂给药,BD 40A的支气管扩张作用在五种激动剂中最为显著,且口服和气雾剂给药后作用持久。BD 40A通过皮下途径增加心率的作用与异丙肾上腺素相似,比曲美托喹酚、奥西那林和沙丁胺醇更强。口服时,BD 40A的心脏刺激作用比异丙肾上腺素、曲美托喹酚和沙丁胺醇更强。然而,在清醒豚鼠中,皮下给药时支气管选择性(ED30次/分钟与ED50的比值)的顺序为沙丁胺醇>BD 40A = 曲美托喹酚>奥西那林>异丙肾上腺素,口服给药时顺序为BD 40A = 沙丁胺醇>曲美托喹酚 = 异丙肾上腺素。奥西那林口服时在豚鼠中未显示出β-刺激作用。在豚鼠中,BD 40A与沙丁胺醇一样,似乎是一种β2-肾上腺素能受体激动剂。

相似文献

1
Cardiorespiratory activitirs of 3-formylamino-4-hydroxy-alpha-(n-1-methyl-2-p-methoxyphenethylaminomethyl)-benzylalcohol-hemifumarate(BD 40A) and some other beta-adrenoceptor stimulants in conscious guinea pigs.3-甲酰氨基-4-羟基-α-(N-1-甲基-2-对甲氧基苯乙氨基甲基)-苄醇半富马酸盐(BD 40A)及其他一些β-肾上腺素能兴奋剂对清醒豚鼠的心肺活动
Arzneimittelforschung. 1976;26(7):1337-40.
2
Comparison of the action of BD 40 A and some other beta-adrenoceptor stimulants on the isolated trachea and atria of the guinea pig.BD 40 A与其他一些β-肾上腺素能受体兴奋剂对豚鼠离体气管和心房作用的比较。
Arzneimittelforschung. 1976;26(5):839-42.
3
[Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors (author's transl)].新型支气管溶解剂NAB 365(克仑特罗)对肾上腺素能β2受体具有选择性活性的药理作用概况(作者译)
Arzneimittelforschung. 1976;26(7a):1404-20.
4
The bronchodilator and cardiac stimulant effects of Thll65a, salbutamol and isoproterenol.Thll65a、沙丁胺醇和异丙肾上腺素的支气管扩张及心脏刺激作用。
J Pharmacol Exp Ther. 1973 Sep;186(3):472-81.
5
Pharmacodynamics of a new selective beta2-adrenergic bronchodilator 3-(4-methoxybenzylamino)-4-hydroxy-alpha-(tert. butylaminomethyl)-benzyl-alcohol, HCl (QH25).新型选择性β2-肾上腺素能支气管扩张剂3-(4-甲氧基苄基氨基)-4-羟基-α-(叔丁氨基甲基)-苄醇盐酸盐(QH25)的药效学
Acta Pharmacol Toxicol (Copenh). 1977 Jan;40(1):42-64. doi: 10.1111/j.1600-0773.1977.tb02052.x.
6
Pharmacological studies of mabuterol, a new selective beta 2-stimulant. I: Bronchodilating effect.新型选择性β2激动剂马布特罗的药理学研究。I:支气管扩张作用。
Arzneimittelforschung. 1984;34(11A):1633-40.
7
Effects of formoterol (BD 40A), a beta-adrenoceptor stimulant, on isolated guinea-pig lung parenchymal strips and antigen-induced SRS-A release in rats.β-肾上腺素能兴奋剂福莫特罗(BD 40A)对豚鼠离体肺实质条及大鼠抗原诱导的慢反应物质A释放的影响。
Arch Int Pharmacodyn Ther. 1984 Jan;267(1):91-102.
8
Comparative heart rate effects of oral administration of bitolterol, terbutaline and trimetoquinol in unanesthetized dogs.口服比托特罗、特布他林和曲美托喹对未麻醉犬心率的比较影响。
Res Commun Chem Pathol Pharmacol. 1980 Apr;28(1):185-8.
9
Determination of bioavailability on the basis of tachycardia after intravenous and oral administration of fenoterol, orciprenaline and salbutamol in non-anaesthetized rats.在未麻醉大鼠中静脉注射和口服非诺特罗、奥西那林和沙丁胺醇后基于心动过速测定生物利用度。
Arzneimittelforschung. 1985;35(1A):406-8.
10
A comparison of the pharmacology of salbutamol with that of isoprenaline, orciprenaline and trimetoquinol.沙丁胺醇与异丙肾上腺素、奥西那林和曲美托喹啉的药理学比较。
Postgrad Med J. 1971 Mar;47:Suppl:11-6.

引用本文的文献

1
A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β-Agonists Used for Asthma and COPD.用于哮喘和慢性阻塞性肺疾病的当前短效、长效和超长效β受体激动剂的分子药理学特性比较
Pharmacol Res Perspect. 2025 Oct;13(5):e70154. doi: 10.1002/prp2.70154.
2
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.哮喘和 COPD:聚焦β-激动剂——过去、现在和未来。
Handb Exp Pharmacol. 2024;285:369-451. doi: 10.1007/164_2023_679.
3
Multiplexed Optical Sensors in Arrayed Islands of Cells for multimodal recordings of cellular physiology.
用于细胞多模态生理记录的细胞岛状排列中的多路复用光学传感器。
Nat Commun. 2020 Aug 4;11(1):3881. doi: 10.1038/s41467-020-17607-5.
4
Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide.重度慢性阻塞性肺疾病急性加重的管理:聚焦于丙酸倍氯米松/福莫特罗/格隆溴铵
Int J Chron Obstruct Pulmon Dis. 2018 Jul 30;13:2319-2333. doi: 10.2147/COPD.S147484. eCollection 2018.
5
Beta-adrenoceptor regulation and functional responses in the guinea-pig following chronic administration of the long-acting beta 2-adrenoceptor agonist formoterol.长期给予长效β2肾上腺素能激动剂福莫特罗后豚鼠体内β肾上腺素能受体的调节及功能反应
Naunyn Schmiedebergs Arch Pharmacol. 1995 Jun;351(6):576-88. doi: 10.1007/BF00170156.
6
Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.福莫特罗,一种新型长效β2受体激动剂,每日吸入两次,与沙丁胺醇治疗哮喘的疗效比较。
Thorax. 1990 Apr;45(4):259-61. doi: 10.1136/thx.45.4.259.
7
Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.福莫特罗。其药理学特性及在可逆性阻塞性气道疾病中的治疗潜力综述。
Drugs. 1991 Jul;42(1):115-37. doi: 10.2165/00003495-199142010-00007.